Nathanael S. GRAY,Michael ECK,Pasi JANNE,Hwan Geun CHOI,Jaebong JANG,Kwok-Kin WONG
申请号：
US16440803
公开号：
US20200002279A1
申请日:
2019.06.13
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The disclosure relates to a compound having Formula (I′；):andin particular, Compound I-126:which modulates the activity of EGFR, a pharmaceutical composition comprising the compound, and a method of treating or preventing a disease in which EGFR plays a role.
